FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans

Qiumei Du, Larry Huynh, Fatma S. Coskun, Erika Molina, Matthew King, Prithvi Raj, Shaheen Khan, Igor Dozmorov, Christine M. Seroogy, Christian Wysocki,

Journal of Clinical Investigation · 2019 · 45 citations · 49 references

DOIFull text

Open access

Concepts

Abstract

T313fsX169 1.5% No No No Multiple viral infections, failure to thrive. Died at 1 yr of age from parainfluenza virus. Pt. 1 c.1089_1103del15 p.W363C 31% No No No Multiple viral infections, failure to thrive. Died at 1 yr of age from parainfluenza virus. Pt. 2 c.1288C>T p.P430S 100% No No Yes Received BM transplant. Healthy, no recurrent infections, on s.c. gamma globulin therapy. Pt. 2 c.1465delC p.R489fsX61 18% No No Yes Received BM transplant. Healthy, no recurrent infections, on s.c. gamma globulin therapy. Pt. 3 c.1465delC p.R489fsX61 18% No No No Healthy, no recurrent infections. Pt. 4 c.1465delC p.R489fsX61 18% Yes No No Healthy, no recurrent infections. Pt. 5 724C>T p.P242S 95% No No No Developed S. aureus submandibular abscess in infancy; otherwise healthy. Pt. 6 958C>T p.R320W 2% No No No Healthy, no recurrent infections. Pt. 7 962A>G p.H321R 82% Yes Yes No Died in infancy from coronavirus encephalitis. Also had a heterozygous DOCK8 mutation. Pt. 8 982T>C p.C328R 16% No No No Healthy, no recurrent infections. Pt. 9 1075G>A p.E359K 63% No No No Healthy, no recurrent infections. Pt. 10 1201_1206del16 p.P401AfsX144 3% No No No Also had heterozygous DOCK8 and CHD7 mutations with no congenital anomalies. Pt. 11 1201_1206del16 p.P401AfsX144 3% No No No Healthy, no recurrent infections. Pt. 12 1201_1206del16 p.P401AfsX144 3% No No No Healthy, no recurrent infections. Received live virus vaccines. Pt. 13 1201_1206del16 p.P401AfsX144 3% No Yes No Healthy, no recurrent infections. Pt. 14 1201_1206del16 p.P401AfsX144 3% No No No Born prematurely due to maternal infection. Currently healthy with no recurrent infections. Pt. 15 1293delC p.P432fsX118 2% No No Yes Low numbers through ~3 mo when alternate therapy was given. Pt. 16 1418delC p.

References

49